51 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
18
Drug Repurposing of Histone Deacetylase Inhibitors That Alleviate Neutrophilic Inflammation in Acute Lung Injury and Idiopathic Pulmonary Fibrosis via Inhibiting Leukotriene A4 Hydrolase and Blocking LTB4 Biosynthesis.
East China University of Science and Technology
12
Novel acetamidothiazole derivatives: synthesis and in vitro anticancer evaluation.
University of Mansoura
28
Identification of benzofuran central cores for the inhibition of leukotriene A(4) hydrolase.
Janssen Research and Development
17
Optimization of 5-hydroxytryptamines as dual function inhibitors targeting phospholipase A2 and leukotriene A4 hydrolase.
Peking University
27
Azabenzthiazole inhibitors of leukotriene A4 hydrolase.
Janssen Research and Development
12
Rapid and efficient synthesis of a novel series of substituted aminobenzosuberone derivatives as potent, selective, non-peptidic neutral aminopeptidase inhibitors.
University of Upper Alsace
37
Synthesis of potent leukotriene A(4) hydrolase inhibitors. Identification of 3-[methyl[3-[4-(phenylmethyl)phenoxy]propyl]amino]propanoic acid.
Pfizer
71
Structure-activity relationship studies on 1-[2-(4-Phenylphenoxy)ethyl]pyrrolidine (SC-22716), a potent inhibitor of leukotriene A(4) (LTA(4)) hydrolase.
Searle Research and Development
15
Kelatorphan and related analogs: potent and selective inhibitors of leukotriene A4 hydrolase
TBA
46
5-Lipoxygenase-activating protein (FLAP) inhibitors. Part 4: development of 3-[3-tert-butylsulfanyl-1-[4-(6-ethoxypyridin-3-yl)benzyl]-5-(5-methylpyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethylpropionic acid (AM803), a potent, oral, once daily FLAP inhibitor.
Amira Pharmaceuticals
27
Discovery of dual target inhibitors against cyclooxygenases and leukotriene A4 hydrolyase.
Peking University
26
Pharmacophore-based virtual screening and Bayesian model for the identification of potential human leukotriene A4 hydrolase inhibitors.
Gyeongsang National University (Gnu)
9
Amino-benzosuberone: a novel warhead for selective inhibition of human aminopeptidase-N/CD13.
Merck Sharpe and Dohme
23
Discovery of novel leukotriene A4 hydrolase inhibitors based on piperidine and piperazine scaffolds.
Decode Chemistry
14
Discovery of 4-[(2S)-2-{[4-(4-chlorophenoxy)phenoxy]methyl}-1-pyrrolidinyl]butanoic acid (DG-051) as a novel leukotriene A4 hydrolase inhibitor of leukotriene B4 biosynthesis.
Decode Chemistry
18
Discovery of leukotriene A4 hydrolase inhibitors using metabolomics biased fragment crystallography.
Decode Biostructures
1
Isolation and structure of leukotriene-A4 hydrolase inhibitor: 8(S)-amino-2(R)-methyl-7-oxononanoic acid produced by Streptomyces diastaticus.
Searle Research and Development
4
Discovery of multitarget inhibitors by combining molecular docking with common pharmacophore matching.
Peking University
43
Synthesis and biological evaluation of N-mercaptoacylcysteine derivatives as leukotriene A4 hydrolase inhibitors.
Santen Pharmaceutical
7
Activation and inhibition of leukotriene A4 hydrolase aminopeptidase activity by diphenyl ether and derivatives.
Peking University
16
Synthesis and biological evaluation of N-mercaptoacylproline and N-mercaptoacylthiazolidine-4-carboxylic acid derivatives as leukotriene A4 hydrolase inhibitors.
Santen Pharmaceutical
31
Discovery of novel and potent aryl diamines as leukotriene A4 hydrolase inhibitors.
Berlex Biosciences
38
Synthesis of N-alkyl glycine amides as potent inhibitors of leukotriene A4 hydrolase.
Berlex Biosciences
10
Dual Modulator of FXR and HSD17B13: Revitalizing FXR Therapies in MASH.
The Fifth Affiliated Hospital of Guangxi Medical University & The First People's Hospital of Nanning
3
NVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family.
Johann Wolfgang Goethe University
9
Synthesis and Evaluation of diaryl ether modulators of the leukotriene A4 hydrolase aminopeptidase activity.
George Mason University
20
Structure-Guided Elaboration of a Fragment-Like Hit into an Orally Efficacious Leukotriene A4 Hydrolase Inhibitor.
Novartis Pharma
26
ERAP Inhibitors in Autoimmunity and Immuno-Oncology: Medicinal Chemistry Insights.
University of Lille
14
Discovery of Amino Alcohols as Highly Potent, Selective, and Orally Efficacious Inhibitors of Leukotriene A4 Hydrolase.
Novartis Pharma
36
Fragment-to-Lead Medicinal Chemistry Publications in 2020.
Vrije Universiteit Amsterdam
18
Synthesis of imidazopyridines and purines as potent inhibitors of leukotriene A4 hydrolase.
Pfizer
26
Pyrrolidine and piperidine analogues of SC-57461A as potent, orally active inhibitors of leukotriene A(4) hydrolase.
Pharmacia
13
Computer-Aided Fragment Growing Strategies to Design Dual Inhibitors of Soluble Epoxide Hydrolase and LTA4 Hydrolase.
Goethe-University
3
Effect of Modifier Structure on the Activation of Leukotriene A
George Mason University
17
Design of Dual Inhibitors of Soluble Epoxide Hydrolase and LTA
Goethe University Frankfurt
11
Recent developments in the synthesis and applications of phosphinic peptide analogs.
Wroclaw University of Technology
29
Development of selective tight-binding inhibitors of leukotriene A4 hydrolase.
Scripps Research Institute
7
NEUROACTIVE STEROIDS SUBSTITUTED IN POSITION 10 WITH A CYCLIC GROUP FOR USE IN THE TREATMENT OF CNS DISORDERS
Sage Therapeutics
25
SMALL MOLECULE REGULATORS OF ALVEOLAR TYPE 2 CELL PROLIFERATION FOR THE TREATMENT OF PULMONARY DISEASES
THE SCRIPPS RESEARCH INSTITUTE
8
Substituted amino six-membered saturated heteroalicycles as long-acting DPP-IV inhibitors
Centaurus Biopharma
25
Design, synthesis and biological screening of some novel celecoxib and etoricoxib analogs with promising COX-2 selectivity, anti-inflammatory activity and gastric safety profile.
Fayoum University
76
Conformationally restricted urea inhibitors of soluble epoxide hydrolase
University of California